Last $73.23 USD
Change Today +2.23 / 3.14%
Volume 739.2K
BMRN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 12:32 PM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jean-Jacques Bienaimé

Chief Executive Officer and Director, BioMarin Pharmaceutical Inc.
AgeTotal Calculated CompensationThis person is connected to 40 board members in 4 different organizations across 8 different industries.

See Board Relationships
61$11,364,038
As of Fiscal Year 2013

Background*

Mr. Jean-Jacques Bienaime has been the Chief Executive Officer of Biomarin Pharmaceutical Inc. since May 2005. Mr. Bienaime served as the Chief Executive Officer and President of Danisco US Inc. (formerly Genencor) from November 2002 to April 2005. He has over 25 years of experience in the biotechnology and pharmaceutical industries. Before Genencor, Mr. Bienaime served as the President since June 1998, Chief Executive Officer since February 1999 and Chief Operating ...

Read Full Background

Corporate Headquarters*

770 Lindaro Street
San Rafael, California 94901

United States

Phone: 415-506-6700
Fax: 415-382-7889

Board Members Memberships*

Prior
Former Lead Director
Former Director
1999-N/A
Lead Director, Member of Audit Committee and Member of Compensation Committee
1999-N/A
Former Director
2002-2005
Former President and Director
2004-2012
Former Lead Independent Director, Chairman of Nominating & Governance Committee and Member of Audit Committee
2005-Present
Chief Executive Officer and Director
2010-2014
Former Independent Director
2012-2014
Former Director and Member of Compensation Committee
2013-Present
Director and Member of Compensation Committee

Education*

MBA
University of Pennsylvania - The Wharton School
BS
ESCP Europe

Other Affiliations*

Annual Compensation*

Salary$868,796
Total Annual Compensation$868,796

Stock Options*

Restricted Stock Awards$2,563,218
All Other Compensation$27,059
Exercised Options186,000
Exercised Options Value$9,653,608
Exercisable Options1,833,003
Exercisable Options Value$84,589,243
Unexercisable Options401,261
Unexercisable Options Value$9,034,294
Total Value of Options$103,277,144
Total Number of Options2,420,264

Total Compensation*

Total Annual Cash Compensation$1,949,885
Total Short Term Compensation$868,796
Other Long Term Compensation$2,590,277
Total Calculated Compensation$11,364,038
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BMRN:US $73.23 USD +2.23

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
W. Thomas Amick Chief Executive Officer, President and Director
Dendreon Corp.
--
Jean-Paul Clozel M.D.Founder, Chief Executive Officer, Member of Management Board and Director
Actelion Ltd.
SFr.2.6M
Rajesh C. Shrotriya M.D.Chairman, Chief Executive Officer, Chairman of Product Acquisition Committee and Chairman of Placement Committee
Spectrum Pharmaceuticals, Inc.
$1.8M
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOMARIN PHARMACEUTICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.